Journal
HORMONE RESEARCH IN PAEDIATRICS
Volume 76, Issue 2, Pages 73-85Publisher
KARGER
DOI: 10.1159/000327794
Keywords
Congenital adrenal hyperplasia; 21-Hydroxylase deficiency; Obesity; Hypertension; Osteoporosis; Fertility
Categories
Funding
- European Community [PIEF-GA-2008-221058]
- Medical Research Council UK [0900567]
- Wellcome Trust [GR079865MA]
- Medical Research Council [G0900567] Funding Source: researchfish
- MRC [G0900567] Funding Source: UKRI
Ask authors/readers for more resources
Following the introduction of life-saving glucocorticoid replacement 60 years ago, congenital adrenal hyperplasia (CAH) has evolved from being perceived as a paediatric disorder to being recognized as a lifelong, chronic condition affecting patients of all age groups. Increasing evidence suggests that patients with CAH have an increased risk to develop health problems during adult life, with signs and symptoms of forerunner conditions of adult disease already emerging during the time of paediatric care. Transition of paediatric CAH patients to medical care in the adult setting is an important step to ensure optimal lifelong treatment, aiming to achieve good health and normal life expectancy and quality of life. Thus, primary and secondary prevention of health problems has to become a task of increasing importance for those involved in the care of CAH patients throughout their life. Copyright (C) 2011 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available